A new screening method combining CRISPR genome editing with single-cell RNA sequencing enables the simultaneous analysis of thousands of genes in individual cells. This approach, called CROP-seq, allows researchers to study complex biological mechanisms and identify novel drug targets more efficiently than traditional methods.
A new study identifies malondialdehyde as a key player in hepatic inflammation and finds it can be neutralized by specific natural antibodies. The research provides a promising approach towards a potential therapy for non-alcoholic fatty liver disease.
Researchers discovered a subset of lung tumors sensitive to MEK inhibitors, offering new hope for up to 10% of lung cancer patients with ATM mutant gene. The study's findings could pave the way for precision medicine and targeted treatment strategies.
Researchers found that artemisinins transform glucagon-producing alpha cells into insulin-producing cells by activating GABA receptors, producing insulin. The study uses FDA-approved malaria drugs and has been shown to increase beta cell mass and improve blood sugar homeostasis in animal models.
Scientists have established comprehensive maps of the human epigenome, revealing how genes are active in specific cells. The maps, published by the International Human Epigenome Consortium, provide insights into cellular differentiation and potential new treatments for diseases.
Scientists discover that heme molecule interferes with macrophage cytoskeleton, immobilizing them and preventing immune cells from eliminating bacteria. Quinine, an existing malaria medication, restores functionality of affected macrophages, paving the way for new treatment possibilities.
Scientists discovered a rare gene mutation that impairs lymphocyte development and function, providing new insights into the human immune system. A personalized therapy was also identified, using an approved drug to reverse some effects of the deficiency.
A new tool for precision medicine has been developed through epigenetic analysis, which addresses key limitations of genetic testing. This technology provides unprecedented insights into disease mechanisms and can help identify suitable treatments for individual patients.